Effect of selective laser trabeculoplasty and standard medical treatment on day tension curve and intra-ocular pressure
| ISRCTN | ISRCTN17339574 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17339574 |
| Protocol serial number | N0183168499 |
| Sponsor | Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK) |
| Funder | The Mid Yorkshire Hospitals NHS Trust (UK) |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 19/05/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mrs M Nagar
Scientific
Scientific
Consultant Ophthalmologist
The Mid Yorkshire Hospitals NHS Trust
Clayton eye Centre
Clayton Hospital
Wakefield
WF1 4EE
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | What is the effect of selective laser trabeculoplasty and Xalatan eye drops on intra-ocular pressure fluctuation? An earlier study (see http://www.controlled-trials.com/ISRCTN77145641) explored whether 90, 180 or 360 degrees of laser treatment was more effective. This study looks at effect throughout the day of 360 degrees of treatment. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Eye Diseases: Glaucoma |
| Intervention | Randomised Clinical Trial. Randomisation to [A] 360 degree selective laser trabeculoplasty or [B] standard medical treatment. |
| Intervention type | Other |
| Primary outcome measure(s) |
Intra-ocular pressure, and daytime tension curve. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/07/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 40 |
| Key inclusion criteria | Patients with newly diagnosed early glaucoma or ocular hypertension. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/07/2005 |
| Date of final enrolment | 01/07/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Consultant Ophthalmologist
Wakefield
WF1 4EE
United Kingdom
WF1 4EE
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/04/2009 | Yes | No |
